Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021

More articles from 1-Minute Consult

  • You have access
    Fundic gland polyps: Should my patient stop taking PPIs?
    Jiafei (Carolyn) Niu, DO and Yi Qin, MD
    Cleveland Clinic Journal of Medicine March 2023, 90 (3) 157-160; DOI: https://doi.org/10.3949/ccjm.90a.22058

    Of the 2 types of these polyps, the sporadic type is linked to proton pump inhibitor use, whereas the syndromic type occurs on a background of familial adenomatous polyposis—a key distinction.

  • You have access
    What is the rationale for the laboratory workup for suspected pheochromocytomas and paragangliomas?
    Hiba Z. Hashmi, MD, Muhammad Arslan Arif Maan, MD and Laura LaFave, MD
    Cleveland Clinic Journal of Medicine March 2023, 90 (3) 150-153; DOI: https://doi.org/10.3949/ccjm.90a.20197

    The decision to test is best guided by clinical suspicion. Test results should be interpreted with careful consideration of how the samples were collected.

  • You have access
    What are the treatment options for myasthenia gravis if first-line agents fail?
    Christopher Zust, MD and John A. Morren, MD
    Cleveland Clinic Journal of Medicine February 2023, 90 (2) 81-84; DOI: https://doi.org/10.3949/ccjm.90a.22022

    From 5% to 20% of patients may have a suboptimal response or prohibitive adverse effects over a period of a few weeks to 3 months.

  • You have access
    What are my obligations to my incarcerated patient?
    Farah Acher Kaiksow, MD, MPP, Deval Patel, MD and Norman Fost, MD, MPH
    Cleveland Clinic Journal of Medicine January 2023, 90 (1) 18-21; DOI: https://doi.org/10.3949/ccjm.90a.22003

    A court order authorizes a blood transfusion, but the incarcerated patient refuses the transfusion. As the caregiver, am I obligated to follow the court order against the patient’s wishes?

  • You have access
    Which patients hospitalized with alcohol withdrawal syndrome should receive high-dose parenteral thiamine?
    Rahul B. Ganatra, MD, MPH, Anthony C. Breu, MD and Matthew V. Ronan, MD
    Cleveland Clinic Journal of Medicine January 2023, 90 (1) 22-25; DOI: https://doi.org/10.3949/ccjm.90a.22026

    The authors briefly outline risk factors for Wernicke encephalopathy and when high-dose parenteral thiamine is indicated.

  • You have access
    Does my patient need to be screened or treated for a urinary tract infection?
    Ellen K. Kendall and Yael Mauer, MD, MPH
    Cleveland Clinic Journal of Medicine December 2022, 89 (12) 695-698; DOI: https://doi.org/10.3949/ccjm.89a.21121

    When patients present with symptoms that suggest but are not clearly diagnostic of urinary tract infection, urine studies should be obtained.

  • You have access
    When should antithrombotic therapy be resumed after gastrointestinal bleeding?
    Dushyant Singh Dahiya, MD, Asim Kichloo, MD, FACP, Rawan Amir, MD and Farah Wani, MD
    Cleveland Clinic Journal of Medicine November 2022, 89 (11) 630-633; DOI: https://doi.org/10.3949/ccjm.89a.20189

    The timing should be individualized after considering factors related to the bleeding event, thromboembolic risk, and patient comorbidities.

  • Atrial fibrillation: Rate control or rhythm control?
    You have access
    Atrial fibrillation: Rate control or rhythm control?
    Radhika Deshpande, MBBS, Yasser Al Khadra, MD, Raad Al-Tamimi, MBBS, Nour Albast, MBBS and Mohamed Labedi, MD
    Cleveland Clinic Journal of Medicine October 2022, 89 (10) 567-571; DOI: https://doi.org/10.3949/ccjm.89a.21093

    Rate control has been preferred as the primary approach, but the pendulum is swinging in favor of rhythm control.

  • You have access
    How do I interpret and use quantitative buprenorphine and norbuprenorphine urine levels?
    CME article
    Richard C. Waters, MD, MSc and Matthew Perez, MD
    Cleveland Clinic Journal of Medicine October 2022, 89 (10) 557-560; DOI: https://doi.org/10.3949/ccjm.89a.21019

    Confirmatory testing of urine samples can be useful in outpatient settings where buprenorphine dosing is not directly observed. But retaining and engaging the patient in effective treatment should be the ultimate goals of testing.

  • You have access
    How do we maximize diuresis in acute decompensated heart failure?
    CME article
    Saeid Mirzai, DO, Christopher N. Kanaan, MD, Felix Berglund, MD, Maria Mountis, DO and Heba Wassif, MD, MPH
    Cleveland Clinic Journal of Medicine October 2022, 89 (10) 561-565; DOI: https://doi.org/10.3949/ccjm.89a.22016

    The initial goal is to maximize loop diuretic therapy using urine output or urinary sodium for guidance. Combination therapy can be used when patients respond poorly to escalating loop diuretic doses.

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 24

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2023 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire